Business Daily from THE HINDU group of publications
Thursday, Aug 17, 2006
Business Daily from THE HINDU group of publications Thursday, Aug 17, 2006 |
|
|
|
|
|
|
|
Corporate
-
Research & Development Suven to present pre-clinical data at US forum Our Bureau
Hyderabad , Aug. 16
Suven Life Sciences Ltd has announced that it would be presenting the pre-clinical data of its promising lead compounds, 5-HT6 antagonists, at the global annual meeting of Neuroscience of the Society for Neuroscience at the Georgia World Congress Centre of Atlanta, US, from October14 to 18. In a press release here on Wednesday, the company said more than 30,000 scientists from across the world would be attending this year's meet, a premier venue for neuroscientists to share their research findings. "We are encouraged by the results of these pre-clinical studies which lead us to believe that these selected 5HT6 antagonists may provide a novel, safe and effective approach of treating diseases like mild cognitive impairment, Alzheimer's, Schizophrenia, Parkinson's and obesity," the Suven CEO, Mr Venkat Jasti, said.
More Stories on : Research & Development | Mutual Funds | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|